• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症中的表观遗传学和 microRNAs。

Epigenetics and MicroRNAs in Cancer.

机构信息

Ageing Research Center and Translational Medicine-CeSI-MeT, 66100 Chieti, Italy.

Department of Medical, Oral and Biotechnological Sciences, G. d'Annunzio University Chieti-Pescara, 66100 Chieti, Italy.

出版信息

Int J Mol Sci. 2018 Feb 3;19(2):459. doi: 10.3390/ijms19020459.

DOI:10.3390/ijms19020459
PMID:29401683
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5855681/
Abstract

The ability to reprogram the transcriptional circuitry by remodeling the three-dimensional structure of the genome is exploited by cancer cells to promote tumorigenesis. This reprogramming occurs because of hereditable chromatin chemical modifications and the consequent formation of RNA-protein-DNA complexes that represent the principal actors of the epigenetic phenomena. In this regard, the deregulation of a transcribed non-coding RNA may be both cause and consequence of a cancer-related epigenetic alteration. This review summarizes recent findings that implicate microRNAs in the aberrant epigenetic regulation of cancer cells.

摘要

通过重塑基因组的三维结构来重新编程转录电路的能力被癌细胞利用来促进肿瘤发生。这种重编程是由于可遗传的染色质化学修饰以及随后形成的 RNA-蛋白质-DNA 复合物引起的,这些复合物代表了表观遗传现象的主要因素。在这方面,转录非编码 RNA 的失调可能是与癌症相关的表观遗传改变的原因和结果。这篇综述总结了最近的发现,表明 microRNAs 参与了癌细胞异常的表观遗传调控。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14fe/5855681/4c219ee4f8d0/ijms-19-00459-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14fe/5855681/250fcee90c8c/ijms-19-00459-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14fe/5855681/4c219ee4f8d0/ijms-19-00459-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14fe/5855681/250fcee90c8c/ijms-19-00459-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14fe/5855681/4c219ee4f8d0/ijms-19-00459-g002.jpg

相似文献

1
Epigenetics and MicroRNAs in Cancer.癌症中的表观遗传学和 microRNAs。
Int J Mol Sci. 2018 Feb 3;19(2):459. doi: 10.3390/ijms19020459.
2
Gene methylation in gastric cancer.胃癌中的基因甲基化。
Clin Chim Acta. 2013 Sep 23;424:53-65. doi: 10.1016/j.cca.2013.05.002. Epub 2013 May 10.
3
Epigenetic interplays between DNA demethylation and histone methylation for protecting oncogenesis.DNA 去甲基化与组蛋白甲基化之间的表观遗传相互作用对保护致癌作用。
J Biochem. 2019 Apr 1;165(4):297-299. doi: 10.1093/jb/mvy124.
4
Epigenetics and miRNAs in human cancer.人类癌症中的表观遗传学和 miRNA。
Adv Genet. 2010;70:87-99. doi: 10.1016/B978-0-12-380866-0.60004-6.
5
Epigenetic tête-à-tête: the bilateral relationship between chromatin modifications and DNA methylation.表观遗传学的深入探讨:染色质修饰与DNA甲基化之间的双向关系
Biochem Cell Biol. 2006 Aug;84(4):463-76. doi: 10.1139/o06-090.
6
Targeting histone modifications--epigenetics in cancer.靶向组蛋白修饰——癌症中的表观遗传学。
Curr Opin Cell Biol. 2013 Apr;25(2):184-9. doi: 10.1016/j.ceb.2013.01.001. Epub 2013 Jan 21.
7
MicroRNAs mediated targeting on the Yin-yang dynamics of DNA methylation in disease and development.微小RNA介导的对疾病与发育中DNA甲基化阴阳动态变化的靶向作用。
Int J Biochem Cell Biol. 2015 Oct;67:115-20. doi: 10.1016/j.biocel.2015.05.002. Epub 2015 May 12.
8
Epigenetic Regulation of microRNAs in Cancer: Shortening the Distance from Bench to Bedside.癌症中 microRNAs 的表观遗传调控:缩短从基础到临床的距离。
Int J Mol Sci. 2021 Jul 8;22(14):7350. doi: 10.3390/ijms22147350.
9
DNA methylation and histone modifications in patients with cancer: potential prognostic and therapeutic targets.癌症患者的DNA甲基化和组蛋白修饰:潜在的预后和治疗靶点。
Methods Mol Biol. 2007;361:25-62. doi: 10.1385/1-59745-208-4:25.
10
DNA methylomes, histone codes and miRNAs: tying it all together.DNA甲基化组、组蛋白编码与微小RNA:将它们整合在一起。
Int J Biochem Cell Biol. 2009 Jan;41(1):87-95. doi: 10.1016/j.biocel.2008.09.005. Epub 2008 Sep 13.

引用本文的文献

1
Overcoming Barriers in Cancer Biology Research: Current Limitations and Solutions.克服癌症生物学研究中的障碍:当前的局限性与解决方案
Cancers (Basel). 2025 Jun 23;17(13):2102. doi: 10.3390/cancers17132102.
2
The DNA methylation landscape of musculoskeletal sarcomas.肌肉骨骼肉瘤的DNA甲基化图谱
Explor Target Antitumor Ther. 2025 May 26;6:1002319. doi: 10.37349/etat.2025.1002319. eCollection 2025.
3
promotes the proliferation and migration of gastric cancer cells by inducing microRNA-125a-5p methylation to promote SERPINE1 protein.

本文引用的文献

1
The role of MicroRNAs in human cancer.MicroRNAs 在人类癌症中的作用。
Signal Transduct Target Ther. 2016 Jan 28;1:15004. doi: 10.1038/sigtrans.2015.4. eCollection 2016.
2
Non-coding RNA networks in cancer.癌症中的非编码RNA网络
Nat Rev Cancer. 2018 Jan;18(1):5-18. doi: 10.1038/nrc.2017.99. Epub 2017 Nov 24.
3
The Dark Side of the Epitranscriptome: Chemical Modifications in Long Non-Coding RNAs.长非编码 RNA 中的表观转录组暗面:化学修饰。
通过诱导微小RNA-125a-5p甲基化促进丝氨酸蛋白酶抑制剂E1(SERPINE1)蛋白表达,从而促进胃癌细胞的增殖和迁移。
World J Gastrointest Oncol. 2025 Mar 15;17(3):98703. doi: 10.4251/wjgo.v17.i3.98703.
4
Berberine Inhibits Breast Cancer Stem Cell Development and Decreases Inflammation: Involvement of miRNAs and IL-6.黄连素抑制乳腺癌干细胞发育并减轻炎症:miRNAs和IL-6的作用
Curr Dev Nutr. 2024 Dec 15;9(2):104532. doi: 10.1016/j.cdnut.2024.104532. eCollection 2025 Feb.
5
Unraveling MLL1-fusion leukemia: Epigenetic revelations from an iPS cell point mutation.解析MLL1融合白血病:来自诱导多能干细胞点突变的表观遗传学启示。
J Biol Chem. 2024 Nov;300(11):107825. doi: 10.1016/j.jbc.2024.107825. Epub 2024 Sep 27.
6
Recent progress in Surface-Enhanced Raman Spectroscopy detection of biomarkers in liquid biopsy for breast cancer.表面增强拉曼光谱技术在乳腺癌液体活检生物标志物检测中的最新进展
Front Oncol. 2024 Jul 8;14:1400498. doi: 10.3389/fonc.2024.1400498. eCollection 2024.
7
miR-769-3p inhibits cellular proliferation of KSHV-infected SH-SY5Y cells through targeting mTOR.微小RNA-769-3p通过靶向雷帕霉素靶蛋白抑制卡波西肉瘤相关疱疹病毒感染的SH-SY5Y细胞的细胞增殖。
J Cancer. 2024 Apr 23;15(11):3338-3349. doi: 10.7150/jca.93595. eCollection 2024.
8
miR-218-5p, miR-124-3p and miR-23b-3p act synergistically to modulate the expression of NACC1, proliferation, and apoptosis in C-33A and CaSki cells.微小RNA-218-5p、微小RNA-124-3p和微小RNA-23b-3p协同作用,调节C-33A和CaSki细胞中NACC1的表达、增殖及凋亡。
Noncoding RNA Res. 2024 Feb 27;9(3):720-731. doi: 10.1016/j.ncrna.2024.02.016. eCollection 2024 Sep.
9
lncRNA-microRNA axis in cancer drug resistance: particular focus on signaling pathways.癌症耐药中的长链非编码RNA-微小RNA轴:特别关注信号通路
Med Oncol. 2024 Jan 9;41(2):52. doi: 10.1007/s12032-023-02263-8.
10
Role of miR50103p in predicting the prognosis of hepatocellular carcinoma.miR50103p 在预测肝细胞癌预后中的作用。
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2023;48(9):1281-1295. doi: 10.11817/j.issn.1672-7347.2023.230042.
Int J Mol Sci. 2017 Nov 10;18(11):2387. doi: 10.3390/ijms18112387.
4
LncRNA HOXA11-AS Exerts Oncogenic Functions by Repressing p21 and miR-124 in Uveal Melanoma.长链非编码RNA HOXA11-AS通过抑制葡萄膜黑色素瘤中的p21和miR-124发挥致癌作用。
DNA Cell Biol. 2017 Oct;36(10):837-844. doi: 10.1089/dna.2017.3808. Epub 2017 Jul 27.
5
Suppressing miR-199a-3p by promoter methylation contributes to tumor aggressiveness and cisplatin resistance of ovarian cancer through promoting DDR1 expression.通过启动子甲基化抑制 miR-199a-3p 促进 DDR1 表达,从而导致卵巢癌细胞侵袭性增加和对顺铂耐药。
J Ovarian Res. 2017 Jul 25;10(1):50. doi: 10.1186/s13048-017-0333-4.
6
Extraordinary Cancer Epigenomics: Thinking Outside the Classical Coding and Promoter Box.非凡的癌症表观基因组学:跳出经典编码和启动子框框思考
Trends Cancer. 2016 Oct;2(10):572-584. doi: 10.1016/j.trecan.2016.08.004. Epub 2016 Sep 13.
7
Epigenetics and Cancer Stem Cells: Unleashing, Hijacking, and Restricting Cellular Plasticity.表观遗传学与癌症干细胞:释放、劫持和限制细胞可塑性
Trends Cancer. 2017 May;3(5):372-386. doi: 10.1016/j.trecan.2017.04.004. Epub 2017 May 5.
8
Epigenetic silencing of microRNA-137 enhances ASCT2 expression and tumor glutamine metabolism.微小RNA-137的表观遗传沉默增强了ASCT2表达和肿瘤谷氨酰胺代谢。
Oncogenesis. 2017 Jul 10;6(7):e356. doi: 10.1038/oncsis.2017.59.
9
MicroRNA-137 is negatively associated with clinical outcome and regulates tumor development through EZH2 in cervical cancer.微小 RNA-137 与宫颈癌的临床结果呈负相关,并通过 EZH2 调节肿瘤的发展。
J Cell Biochem. 2018 Jan;119(1):938-947. doi: 10.1002/jcb.26259. Epub 2017 Oct 4.
10
The lincRNA-ROR/miR-145 axis promotes invasion and metastasis in hepatocellular carcinoma via induction of epithelial-mesenchymal transition by targeting ZEB2.长链非编码 RNA-ROR/miR-145 轴通过靶向 ZEB2 诱导上皮-间充质转化促进肝癌的侵袭和转移。
Sci Rep. 2017 Jul 5;7(1):4637. doi: 10.1038/s41598-017-04113-w.